Literature DB >> 22085904

Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis.

Yogi Misra1, Pamela A Bentley, Jeffrey P Bond, Scott Tighe, Timothy Hunter, Feng-Qi Zhao.   

Abstract

A full-term pregnancy early in life reduces lifetime risk of developing breast cancer, and the effect can be mimicked in rodents by full-term pregnancy or short-term treatment with exogenous estrogen and progesterone. To gain insight into the protective mechanism, 15 3-mo-old postpubertal virgin Lewis rats were randomly assigned to three groups: control (C), pregnancy (P), or hormone (H). The P group animals underwent a full-term pregnancy, and H group animals were implanted subcutaneously with silastic capsules filled with ethynyl estradiol and megesterol acetate for 21 days. C and P animals were implanted with sham capsules. On day 21 capsules were removed, which was followed by a 49-day involution period, euthanasia, and mammary tissue collection. Global gene expression was measured using Rat Genome 230.2 Arrays. Histological analysis revealed that P and H treatments induced sustained morphological changes in the mammary gland with significantly increased percentages of mammary parenchyma and stromal tissues and higher ratio of stroma to parenchyma. Transcriptome analysis showed that P and H treatments induced sustained global changes in gene expression in the mammary gland. Analysis of commonly up- and downregulated genes in P and H relative to C treatment showed increased expression of three matrix metallopeptidases (Mmp3, 8, and 12), more differentiated mammary phenotype, enhanced innate and adaptive immunity, and reduced cell proliferation and angiogenic signatures. The sustained morphological and global gene expression changes in mammary tissue after pregnancy and hormone treatment may function together to provide the protective effect against breast cancer.

Entities:  

Mesh:

Year:  2011        PMID: 22085904      PMCID: PMC4116391          DOI: 10.1152/physiolgenomics.00056.2011

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  70 in total

Review 1.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

2.  Differentiation and breast cancer.

Authors:  J Russo; I H Russo
Journal:  Medicina (B Aires)       Date:  1997       Impact factor: 0.653

Review 3.  The role of the microenvironment in mammary gland development and cancer.

Authors:  Kornelia Polyak; Raghu Kalluri
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-30       Impact factor: 10.005

4.  Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.

Authors:  Heath B Acuff; Mark Sinnamon; Barbara Fingleton; Braden Boone; Shawn E Levy; Xiwu Chen; Ambra Pozzi; David P Carbone; Donald R Schwartz; Kamiar Moin; Bonnie F Sloane; Lynn M Matrisian
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

5.  Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.

Authors:  R C Guzman; J Yang; L Rajkumar; G Thordarson; X Chen; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  ICSBP-mediated immune protection against BCR-ABL-induced leukemia requires the CCL6 and CCL9 chemokines.

Authors:  Valentina Nardi; Olaia Naveiras; Mohammad Azam; George Q Daley
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

7.  Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone.

Authors:  C J Grubbs; D R Farnell; D L Hill; K C McDonough
Journal:  J Natl Cancer Inst       Date:  1985-04       Impact factor: 13.506

8.  BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.

Authors:  Claudia D Baldus; Stephan M Tanner; Amy S Ruppert; Susan P Whitman; Kellie J Archer; Guido Marcucci; Michael A Caligiuri; Andrew J Carroll; James W Vardiman; Bayard L Powell; Steven L Allen; Joseph O Moore; Richard A Larson; Jonathan E Kolitz; Albert de la Chapelle; Clara D Bloomfield
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

9.  Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer.

Authors:  Theresa Casey; Jeffrey Bond; Scott Tighe; Timothy Hunter; Laura Lintault; Osman Patel; Jonathan Eneman; Abigail Crocker; Jeffrey White; Joseph Tessitore; Mary Stanley; Seth Harlow; Donald Weaver; Hyman Muss; Karen Plaut
Journal:  Breast Cancer Res Treat       Date:  2008-03-29       Impact factor: 4.872

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  6 in total

1.  Association of breast cancer and obesity in a homogeneous population from Spain.

Authors:  A B Crujeiras; J Cueva; M Vieito; T Curiel; R López-López; M Pollán; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2012-04-18       Impact factor: 4.256

2.  Mimicking pregnancy as a strategy for breast cancer prevention.

Authors:  Julia Santucci-Pereira; Christina George; David Armiss; Irma H Russo; Johana E Vanegas; Fathima Sheriff; Ricardo Lopez de Cicco; Yanrong Su; Patricia A Russo; Lucas T Bidinotto; Jose Russo
Journal:  Breast Cancer Manag       Date:  2013-07-01

3.  Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling.

Authors:  Sonali Jindal; Dexiang Gao; Pat Bell; Grethe Albrektsen; Susan M Edgerton; Christine B Ambrosone; Ann D Thor; Virginia F Borges; Pepper Schedin
Journal:  Breast Cancer Res       Date:  2014-03-28       Impact factor: 6.466

4.  Effects of parity and serum prolactin levels on the incidence and regression of DMBA-induced tumors in OFA hr/hr rats.

Authors:  Corina V Sasso; Flavia E Santiano; Constanza M López-Fontana; Virginia Pistone-Creydt; Marcelo E Ezquer; María B Hapon; Graciela A Jahn; Rubén W Carón
Journal:  Biomed Res Int       Date:  2014-07-17       Impact factor: 3.411

Review 5.  Potential Mechanisms underlying the Protective Effect of Pregnancy against Breast Cancer: A Focus on the IGF Pathway.

Authors:  Tiffany A Katz
Journal:  Front Oncol       Date:  2016-10-26       Impact factor: 6.244

6.  The genomic signature of breast cancer prevention.

Authors:  Jose Russo; Julia Santucci-Pereira; Irma H Russo
Journal:  Genes (Basel)       Date:  2014-02-26       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.